Zinc fertilisation increases tolerance to Rhizoctonia solani (AG 8) in Medicago truncatula

The effect of Zn fertilisation on tolerance of Medicago truncatula to infection by the root-rotting pathogen Rhizoctonia solani (AG 8) was studied in a field survey and in two experiments in controlled conditions. From the field survey, the concentration of Zn in the shoots of medics was found to be inversely related to the severity of disease on the root. Overall, the addition of Zn to Zn-deficient soil in controlled environment experiments resulted in reduced yield loss in the presence of R. solani, a reduction in disease score and no change in the concentration of nutrients in the shoots. However, under Zn deficiency, increasing levels of added R. solani resulted in significant yield loss, an increase in disease score and a reduction in concentration of Zn in the roots. This occurred despite a decrease in the number of infection sites caused by the fungus on the root and a lower amount of R. solani DNA extracted in medics deficient in Zn compared with plants supplied with Zn. While plants supplied with Zn were able to maintain a stable concentration of Zn in the shoots, the concentration of Zn in the roots also declined with increasing levels of R. solani. In conclusion, Zn application does not directly inhibit infection by R. solani, nor reduce its pathogenicity, but it does strongly increase root growth. The net result is that Zn-sufficient plants are more tolerant to the effects of root pruning by the fungus than Zn-deficient plants.     

Genome-wide association mapping of Fusarium head blight resistance in contemporary barley breeding germplasm

Utilization of quantitative trait loci (QTL) identified in bi-parental mapping populations has had limited success for improving complex quantitative traits with low to moderate heritability. Association mapping in contemporary breeding germplasm may lead to more effective marker strategies for crop improvement. To test this approach, we conducted association mapping of two complex traits with moderate heritability; Fusarium head blight (FHB) severity and the grain concentration of mycotoxin associated with disease, deoxynivalenol (DON). To map FHB resistance in barley, 768 breeding lines were evaluated in 2006 and 2007 in four locations. All lines were genotyped with 1,536 SNP markers and QTL were mapped using a mixed model that accounts for relatedness among lines. Average linkage disequilibrium within the breeding germplasm extended beyond 4 cM. Four QTL were identified for FHB severity and eight QTL were identified for the DON concentration in two independent sets of breeding lines. The QTL effects were small, explaining 1–3% of the phenotypic variation, as might be expected for complex polygenic traits. We show that using breeding germplasm to map QTL can complement bi-parental mapping studies by providing independent validation, mapping QTL with more precision, resolving questions of linkage and pleiotropy, and identifying genetic markers that can be applied immediately in crop improvement.     

Open-label comparative clinical study of chlorproguanil-dapsone fixed dose combination (Lapdap) alone or with three different doses of artesunate for uncomplicated Plasmodium falciparum malaria

The objective of this study was to determine the appropriate dose of artesunate for use in a fixed dose combination therapy with chlorproguanil−dapsone (CPG−DDS) for the treatment of uncomplicated falciparum malaria.

Methods

Open-label clinical trial comparing CPG−DDS alone or with artesunate 4, 2, or 1 mg/kg at medical centers in Blantyre, Malawi and Farafenni, The Gambia. The trial was conducted between June 2002 and February 2005, including 116 adults (median age 27 years) and 107 children (median age 38 months) with acute uncomplicated Plasmodium falciparum malaria. Subjects were randomized into 4 groups to receive CPG–DDS alone or plus 4, 2 or 1 mg/kg of artesunate once daily for 3 days. Assessments took place on Days 0−3 in hospital and follow-up on Days 7 and 14 as out-patients. Efficacy was evaluated in the Day 3 per-protocol (PP) population using mean time to reduce baseline parasitemia by 90% (PC90). A number of secondary outcomes were also included. Appropriate artesunate dose was determined using a pre-defined decision matrix based on primary and secondary outcomes. Treatment emergent adverse events were recorded from clinical assessments and blood parameters. Safety was evaluated in the intent to treat (ITT) population.

Results

In the Day 3 PP population for the adult group (N = 85), mean time to PC90 was 19.1 h in the CPG−DDS group, significantly longer than for the +artesunate 1 mg/kg (12.5 h; treatment difference −6.6 h [95%CI −11.8, −1.5]), 2 mg/kg (10.7 h; −8.4 h [95%CI −13.6, −3.2]) and 4 mg/kg (10.3 h; −8.7 h [95%CI −14.1, −3.2]) groups. For children in the Day 3 PP population (N = 92), mean time to PC90 was 21.1 h in the CPG−DDS group, similar to the +artesunate 1 mg/kg group (17.7 h; −3.3 h [95%CI −8.6, 2.0]), though the +artesunate 2 mg/kg and 4 mg/kg groups had significantly shorter mean times to PC90 versus CPG−DDS; 14.4 h (treatment difference −6.4 h [95%CI −11.7, −1.0]) and 12.8 h (−7.4 h [95%CI −12.9, −1.8]), respectively. An analysis of mean time to PC90 for the Day 14 PP and ITT populations was consistent with the primary analysis. Treatment emergent, drug-related adverse events were experienced in 35.3% (41/116) of adults and 70.1% (75/107) of children; mostly hematological and gastroenterological. The nature and incidence of adverse events was similar between the groups. No dose-related changes in laboratory parameters were observed. Nine serious adverse events due to any cause occurred in five subjects including two cases of hemolysis believed to be associated with drug treatment (one adult, one child). One adult died of anaphylactic shock, not associated with investigational therapy.

Conclusions

CPG–DDS plus artesunate demonstrated advantages over CPG–DDS alone for the primary efficacy endpoint (mean time to PC90) except in children for the 1 mg/kg artesunate dose. Based on a pre-defined decision matrix, the primary endpoint in the child group supported an artesunate dose of 4 mg/kg. Secondary endpoints also supported a 4 mg/kg artesunate dose to take forward into the remainder of the development program.

Trial Registration

ClinicalTrials.gov {"type":"clinical-trial","attrs":{"text":"NCT00519467","term_id":"NCT00519467"}}NCT00519467     

Prevalence of Comorbidities,Overweight and Obesity in an International Sample of People with Multiple Sclerosis and Associations with Modifiable Lifestyle Factors

Multiple sclerosis (MS) is a chronic neurological disorder, often affecting young people. Comorbid disorders such as depression, anxiety and hypertension are common and can affect disease course, treatment, and quality of life (QOL) of people with MS (PwMS). The associations between comorbidities, body mass index (BMI) and health outcomes are not well studied in MS, although research shows most PwMS are overweight. Most data on the prevalence of comorbidities and obesity in PwMS comes from North American populations. This study describes the prevalence of comorbidities, overweight and obesity and associations with modifiable factors in an international sample of PwMS recruited online through social media, MS societies and websites. The online survey consisted of validated and researcher-devised instruments to assess self-reported health outcomes and lifestyle behaviors. Of the 2399 respondents, 22.5% were overweight, 19.4% were obese and 67.2% reported at least one comorbidity, with back pain (36.2%), depression (31.7%), anxiety (29.1%) and arthritis (13.7%) most prevalent and most limiting in daily activities. Obesity and most comorbid disorders were significantly more prevalent in North America. Obese participants were more likely to have comorbidities, especially diabetes (OR 4.8) and high blood pressure (OR 4.5) but also depression (OR 2.2). Being overweight, obese, or a former, or current smoker was associated with an increase in the number of comorbidities; while healthy diet, physical activity (borderline significant) and moderate alcohol consumption were associated with decreased number of comorbidities. Increasing number of comorbidities was related to worse QOL, increased odds of disability and prior relapse. Obese PwMS had higher odds of disability and lower QOL. The associations between BMI, comorbidities and health outcomes are likely to be bi-directional and associated with lifestyle behaviors. Preventing and treating comorbid disorders and obesity in PwMS is warranted, and advice regarding healthy and risky lifestyle may assist in improving health outcomes.     

Does water and phosphorus uptake limit leaf growth of Rhizoctonia-infected wheat seedlings?

Wheat seedlings infected with a pure inoculum of the root-rotting fungus Rhizoctonia solani were grown in pots designed to fit in pressure chambers, to allow the effects of the Rhizoctonia infection on leaf growth to be studied while maintaining the leaves at elevated water status. Wheat was grown to the third leaf stage in soil inoculated with three different levels of Rhizoctonia, and the pots were then pressurised for seven days to maintain the leaf xylem at the point of bleeding (ie. the leaves were at full turgor). The reduction in leaf expansion caused by Rhizoctonia was not overcome by pressurisation, indicating that a reduced supply of water to the leaves was not responsible for reduced leaf growth. The addition of phosphorus to pots marginally deficient in P did not increase the leaf growth of Rhizoctonia-infected plants, despite increased P uptake to the leaves. These results indicate that a reduced supply of water to the leaves and a supply of phosphorus that was bordering on deficient was not the cause of the growth reduction in seedlings with Rhizoctonia infection. The nature of this reduced growth remains uncertain but may involve growth regulators produced by the fungus, or by the plant as a result of the infection process. The mechanism of these growth reductions is of interest as it may provide a key to the development of plant resistance mechanisms. This revised version was published online in June 2006 with corrections to the Cover Date.     

Interaction between zinc nutritional status of cereals and Rhizoctonia root rot severity

An inverse correlation between plant Zn concentration and the severity of Rhizoctonia root rot, described in an earlier paper, was examined in two experiments in a growth chamber. In the first experiment, wheat (Triticum aestivum cv Songlen) was planted in a Zn deficient soil with and without added Zn, and combined factorially with different inoculum densities of Rhizoctonia solani anastomosis group 8. When Zn was added, the percentage of seminal roots infected with R. solani was significantly lower compared to the treatments without added Zn, showing that low Zn potentiated the disease. A subsequent factorial experiment of four inoculum densities and six Zn levels, (0, 0.01, 0.04, 0.1, 0.4 and 6.0 mg Zn kg^–1 soil) was conducted to investigate the Zn effect in more detail. Disease severity was markedly decreased by the higher Zn applications; the disease score dropped sharply between treatments of Zn_0.04 and Zn_0.1, a difference which was reflected in the plant yield response to Zn. For both experiments the Zn concentrations in shoots were significantly different only among Zn treatments, not among the inoculum treatments. This indicated that inoculum density or disease severity did not reduce Zn concentration in the plant. Thus, disease did not exaggerate Zn deficiency, but rather, Zn sufficiency suppressed disease severity. A potentiating link between Zn nutrition and disease severity is thereby established, although this type of experiment did not indicate the mechanism of the Zn effect.     

Elevational changes in the avian community of a Mesoamerican cloud forest park

Harboring many range‐restricted and specialized species, high elevation tropical cloud forests are diverse habitats represented in many protected areas. Despite this, many such areas receive little practical protection from deforestation and land conversion. Moreover, montane species may be more sensitive to climate change owing to various factors affecting community assembly across elevational gradients. Few studies have used annual monitoring to assess how biological communities in cloud forests may be shifting in response to habitat or climate change or assessed the efficacy of protected areas in buffering these effects. We analyzed avifaunal community trends in a 10‐yr dataset of constant‐effort bird point‐count data in a cloud forest national park in Honduras, Central America. We found that species richness and diversity increased at higher elevations, but decreased at lower elevations. Abundances of most dietary and forest‐dependency groups exhibited similar trends, and many key cloud forest species shifted upslope and/or increased in abundance. Taken together, our results suggest that the avian community is moving upslope and species composition is changing. Results for species richness and diversity were similar when only nondegraded transects were considered, suggesting the role of climate change as an important driver. At lower elevations, however, many species may be negatively affected by increased habitat degradation, favoring species with low forest dependency. Continued habitat conversion and climate change could push the cloud forest bird community further upslope, potentially resulting in increased competition, mortality, and even extirpation of some species. Increased protection is unlikely to mitigate the effects of climate change.